000			02273 a2200601 4500
005			20250515085656.0
264		0	_c20071105
008			200711s 0 0 eng d
022			_a0301-4800
024	7		_a10.3177/jnsv.53.213 _2doi
040			_aNLM _beng _cNLM
100	1		_aMurakami, Yasuko
245	0	0	_aZinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin. _h[electronic resource]
260			_bJournal of nutritional science and vitaminology _cJun 2007
300			_a213-8 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAlanine Transaminase _xblood
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aAscorbic Acid _xadministration & dosage
650	0	4	_aCarnosine _xadministration & dosage
650	0	4	_aDietary Supplements
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFatty Acids, Unsaturated _xmetabolism
650	0	4	_aFemale
650	0	4	_aFlow Cytometry
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOrganometallic Compounds _xadministration & dosage
650	0	4	_aPolyethylene Glycols
650	0	4	_aRecombinant Proteins
650	0	4	_aRibavirin _xtherapeutic use
650	0	4	_aThiobarbituric Acid Reactive Substances _xmetabolism
650	0	4	_aTime Factors
650	0	4	_aTransaminases _xblood
650	0	4	_aTreatment Outcome
650	0	4	_aVitamin E _xadministration & dosage
650	0	4	_aVitamins _xadministration & dosage
650	0	4	_aZinc _xadministration & dosage
650	0	4	_aZinc Compounds _xadministration & dosage
700	1		_aKoyabu, Tomoko
700	1		_aKawashima, Aiko
700	1		_aKakibuchi, Naoko
700	1		_aKawakami, Takayo
700	1		_aTakaguchi, Kouichi
700	1		_aKita, Keiji
700	1		_aOkita, Misako
773	0		_tJournal of nutritional science and vitaminology _gvol. 53 _gno. 3 _gp. 213-8
856	4	0	_uhttps://doi.org/10.3177/jnsv.53.213 _zAvailable from publisher's website
999			_c17399690 _d17399690